The Only Impossible Journey Is The One You Never Begin.
- TONY ROBBINS
Comprehensive Psychiatric Center Est. 1979
The Comprehensive Psychiatric Center was established in 1979 by Dr. Roberto Ruiz, a renowned psychiatrist and recipient of the Nyswander-Dole Award.
It was established as an outpatient drug rehab center to offer specialized substance abuse treatment to individuals grappling with opiate addiction.
As a well-known psychiatrist and pioneer in opiate addiction treatment in South Florida, Dr. Ruiz boasts over four decades of experience in the field.
Today, the outpatient drug rehab center is equipped with a dedicated team, including two other physicians who specialize in addiction, as well as drug counselors and support staff dedicated to driving individuals toward success in their substance abuse treatment journey to recovery.
CPC’s primary objective of is to deliver Medication-Assisted Treatment (MAT) to adults dependent on opioids, ensuring their safety within a medically sound therapeutic setting. We strive to empower our clients by offering educational resources and personalized drug counseling, allowing them to explore and enhance their strengths that contribute to a healthy and productive lifestyle.
Suboxone is a prescription medication that combines naloxone and buprenorphine for opioid addiction. It is primarily used in the treatment of drug addiction and dependence.
Buprenorphine is a partial opioid agonist, which helps to alleviate cravings and withdrawal symptoms, while naloxone serves as an opioid receptor antagonist, preventing misuse and abuse.
Suboxone is administered sublingually and is available in different dosage strengths. It works by binding to the same opioid receptors in the brain, thereby reducing the effects of other opioids and suppressing withdrawal symptoms.
This medication plays a crucial role in medication-assisted substance abuse treatment programs, helping individuals on their journey to recovery from opioid addiction. Research indicates the medication potentially reduces the opioid use disorder mortality by over 50%.